FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Lin

Research Profile

Procedures

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Ronnie L Yeager; Dong Zhao; Yan Lan; Duane Poage; C Thomas Lin; Michael D Duvall
Use of mixed-effect models and tolerance limits to evaluate control cynomolgus monkey body weight change and variability during preclinical toxicology studies.
Xuesong Liu; Joann Palma; Robert Kinders; Yan Shi; Cherrie Donawho; Paul A Ellis; Luis E Rodriguez; Milagros Colon-Lopez; Mary Saltarelli; David LeBlond; C Thomas Lin; David Frost; Yan Luo; Vincent L Giranda
An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors.
Gennadiy Koev; Tatyana Dekhtyar; Lixin Han; Ping Yan; Teresa I Ng; C Thomas Lin; Hongmei Mo; Akhteruzzaman Molla
Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Lin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ronnie L Yeager; Dong Zhao; Yan Lan; Duane Poage; C Thomas Lin; Michael D Duvall
Use of mixed-effect models and tolerance limits to evaluate control cynomolgus monkey body weight change and variability during preclinical toxicology studies.
Regulatory toxicology and pharmacology : RTP 2011;60(1):40-5.
2008: Xuesong Liu; Joann Palma; Robert Kinders; Yan Shi; Cherrie Donawho; Paul A Ellis; Luis E Rodriguez; Milagros Colon-Lopez; Mary Saltarelli; David LeBlond; C Thomas Lin; David Frost; Yan Luo; Vincent L Giranda
An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors.
Analytical biochemistry 2008;381(2):240-7.
2007: Gennadiy Koev; Tatyana Dekhtyar; Lixin Han; Ping Yan; Teresa I Ng; C Thomas Lin; Hongmei Mo; Akhteruzzaman Molla
Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro.
Antiviral research 2007;73(1):78-83.
2004: Ryan M Fryer; Lee C Preusser; Samuel V Calzadilla; Yanhui Hu; Hongyu Xu; Kennan Marsh; Bryan Cox; C Thomas Lin; Murali Gopalakrishnan; Glenn A Reinhart
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
Journal of cardiovascular pharmacology 2004;44(2):137-47.
2002: Akhteruzzaman Molla; Hongmei Mo; Sudthida Vasavanonda; Lixin Han; C Thomas Lin; Ann Hsu; Dale J Kempf
In vitro antiviral interaction of lopinavir with other protease inhibitors.
Antimicrobial agents and chemotherapy 2002;46(7):2249-53.